Hong Kong Baptist University

hkbu.edu.hk

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

80

Active

12

Phase 3

1

Total enrollment

37,208

Pipeline matrix

Showing 3 of 3 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Linzhi Jianghuang Fufang Huoxue Anshen1
Chinese herbal medicine formula1
SCD-21011

Next readouts

  • 2024-11-15
  • 2026-03-15
  • 2028-07

Top conditions

  • Physical Activity6
  • Depressive Symptoms3
  • Sleep3
  • Obesity3
  • Functional Constipation3
  • Constipation3
  • Long Covid192
  • Electro-acupuncture2

Frequently asked questions about Hong Kong Baptist University

How many clinical trials does Hong Kong Baptist University have on ClinicalTrials.gov?
Hong Kong Baptist University is listed as the lead sponsor on 80 clinical trials in ClinicalTrials.gov, 12 of which are currently active (recruiting, enrolling, or ongoing).
How many of Hong Kong Baptist University's trials are in Phase 3?
1 of Hong Kong Baptist University's trials are in Phase 3, spread across 3 active drug programs.
What therapeutic areas does Hong Kong Baptist University focus on?
Hong Kong Baptist University's most-studied conditions on ClinicalTrials.gov are Physical Activity, Depressive Symptoms, Sleep, Obesity, Functional Constipation.
When are Hong Kong Baptist University's next clinical trial readouts?
Hong Kong Baptist University has 3 upcoming primary-completion readouts tracked here; the soonest is “A Single Arm Pilot Study of the Chinese Herbal Medicine Formula (SCD-2101) for the Functional Constipation in the Elderly”, expected around 2024-11-15.